Cargando…

Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses

Fifteen monoclonal antibodies (mAbs) are currently registered and approved for the treatment of a range of different cancers. These mAbs are specific for a limited number of targets (9 in all). Four of these molecules are indeed directed against the B-lymphocyte antigen CD20; 3 against human epiderm...

Descripción completa

Detalles Bibliográficos
Autor principal: Baldo, Brian A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827071/
https://www.ncbi.nlm.nih.gov/pubmed/24251081
http://dx.doi.org/10.4161/onci.26333